Inge van Rossum

Summary

Affiliation: Eli Lilly and Company
Country: USA

Publications

  1. doi Does cannabis use affect treatment outcome in bipolar disorder? A longitudinal analysis
    Inge van Rossum
    Medical Department, Eli Lilly Nederland, Houten, The Netherlands
    J Nerv Ment Dis 197:35-40. 2009
  2. doi Stability and treatment outcome of distinct classes of mania
    Inge van Rossum
    Medical Department, Eli Lilly Nederland, Grootslag 1 5, Houten, The Netherlands
    Eur Psychiatry 23:360-7. 2008
  3. pmc Bipolar disorder and dopamine dysfunction: an indirect approach focusing on tardive movement syndromes in a naturalistic setting
    Inge van Rossum
    Eli Lilly Nederland, Medical Department, Houten, The Netherlands
    BMC Psychiatry 9:16. 2009

Detail Information

Publications3

  1. doi Does cannabis use affect treatment outcome in bipolar disorder? A longitudinal analysis
    Inge van Rossum
    Medical Department, Eli Lilly Nederland, Houten, The Netherlands
    J Nerv Ment Dis 197:35-40. 2009
    ..An independent impact of cannabis use on psychopathologic outcomes in patients with bipolar disorder was apparent, whereas the impact on social outcomes was modest...
  2. doi Stability and treatment outcome of distinct classes of mania
    Inge van Rossum
    Medical Department, Eli Lilly Nederland, Grootslag 1 5, Houten, The Netherlands
    Eur Psychiatry 23:360-7. 2008
    ..Differential treatment course and outcome after 12 weeks of treatment were examined for three distinct classes of patients with acute mania in bipolar disorder...
  3. pmc Bipolar disorder and dopamine dysfunction: an indirect approach focusing on tardive movement syndromes in a naturalistic setting
    Inge van Rossum
    Eli Lilly Nederland, Medical Department, Houten, The Netherlands
    BMC Psychiatry 9:16. 2009
    ..An indirect approach to examine this issue was developed, focusing on associations between dopamine proxy measures observed in BD (dopamine-related clinical traits using tardive movement syndromes as dopamine proxy measure of reference)...